Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype

Giovanni Cazzaniga, Maria Grazia Dell'Oro, Cristina Mecucci, Emanuela Giarin, Riccardo Masetti, Vincenzo Rossi, Franco Locatelli, Massimo F. Martelli, Giuseppe Basso, Andrea Pession, Andrea Biondi, Brunangelo Falini

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein involved in leukemia-associated chromosomal translocations, and it regulates the alternate reading frame (ARF)-p53 tumor-suppressor pathway. Recently, it has been demonstrated that mutations of the NPM1 gene alter the protein at its C-terminal, causing its cytoplasmic localization. Cytoplasmic NPM was detected in 35% of adult patients with primary non-French-American-British (FAB) classification M3 acute myeloid leukemia (AML), associated mainly with normal karyotype. We evaluated the prevalence of the NPM1 gene mutation in non-M3 childhood AML patients enrolled in the ongoing Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP-AML02) protocol in Italy. NPM1 mutations were found in 7 (6.5%) of 107 successfully analyzed patients. NPM1-mutated patients carried a normal karyotype (7/26, 27.1%) and were older in age. Thus, the NPM1 mutation is a frequent abnormality in AML patients without known genetic marker; the mutation may represent a new target to monitor minimal residual disease in AML and a potential candidate for alternative and targeted treatments.

Original languageEnglish
Pages (from-to)1419-1422
Number of pages4
JournalBlood
Volume106
Issue number4
DOIs
Publication statusPublished - Aug 15 2005

Fingerprint

Karyotype
Acute Myeloid Leukemia
Genes
Mutation
Tumors
Proteins
Reading Frames
Genetic Translocation
Acute Promyelocytic Leukemia
Residual Neoplasm
Genetic Markers
Italy
Leukemia
nucleophosmin
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Cazzaniga, G., Dell'Oro, M. G., Mecucci, C., Giarin, E., Masetti, R., Rossi, V., ... Falini, B. (2005). Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood, 106(4), 1419-1422. https://doi.org/10.1182/blood-2005-03-0899

Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. / Cazzaniga, Giovanni; Dell'Oro, Maria Grazia; Mecucci, Cristina; Giarin, Emanuela; Masetti, Riccardo; Rossi, Vincenzo; Locatelli, Franco; Martelli, Massimo F.; Basso, Giuseppe; Pession, Andrea; Biondi, Andrea; Falini, Brunangelo.

In: Blood, Vol. 106, No. 4, 15.08.2005, p. 1419-1422.

Research output: Contribution to journalArticle

Cazzaniga, G, Dell'Oro, MG, Mecucci, C, Giarin, E, Masetti, R, Rossi, V, Locatelli, F, Martelli, MF, Basso, G, Pession, A, Biondi, A & Falini, B 2005, 'Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype', Blood, vol. 106, no. 4, pp. 1419-1422. https://doi.org/10.1182/blood-2005-03-0899
Cazzaniga G, Dell'Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood. 2005 Aug 15;106(4):1419-1422. https://doi.org/10.1182/blood-2005-03-0899
Cazzaniga, Giovanni ; Dell'Oro, Maria Grazia ; Mecucci, Cristina ; Giarin, Emanuela ; Masetti, Riccardo ; Rossi, Vincenzo ; Locatelli, Franco ; Martelli, Massimo F. ; Basso, Giuseppe ; Pession, Andrea ; Biondi, Andrea ; Falini, Brunangelo. / Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. In: Blood. 2005 ; Vol. 106, No. 4. pp. 1419-1422.
@article{41fcff0545704c3b92c7b00db463ddd7,
title = "Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype",
abstract = "Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein involved in leukemia-associated chromosomal translocations, and it regulates the alternate reading frame (ARF)-p53 tumor-suppressor pathway. Recently, it has been demonstrated that mutations of the NPM1 gene alter the protein at its C-terminal, causing its cytoplasmic localization. Cytoplasmic NPM was detected in 35{\%} of adult patients with primary non-French-American-British (FAB) classification M3 acute myeloid leukemia (AML), associated mainly with normal karyotype. We evaluated the prevalence of the NPM1 gene mutation in non-M3 childhood AML patients enrolled in the ongoing Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP-AML02) protocol in Italy. NPM1 mutations were found in 7 (6.5{\%}) of 107 successfully analyzed patients. NPM1-mutated patients carried a normal karyotype (7/26, 27.1{\%}) and were older in age. Thus, the NPM1 mutation is a frequent abnormality in AML patients without known genetic marker; the mutation may represent a new target to monitor minimal residual disease in AML and a potential candidate for alternative and targeted treatments.",
author = "Giovanni Cazzaniga and Dell'Oro, {Maria Grazia} and Cristina Mecucci and Emanuela Giarin and Riccardo Masetti and Vincenzo Rossi and Franco Locatelli and Martelli, {Massimo F.} and Giuseppe Basso and Andrea Pession and Andrea Biondi and Brunangelo Falini",
year = "2005",
month = "8",
day = "15",
doi = "10.1182/blood-2005-03-0899",
language = "English",
volume = "106",
pages = "1419--1422",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype

AU - Cazzaniga, Giovanni

AU - Dell'Oro, Maria Grazia

AU - Mecucci, Cristina

AU - Giarin, Emanuela

AU - Masetti, Riccardo

AU - Rossi, Vincenzo

AU - Locatelli, Franco

AU - Martelli, Massimo F.

AU - Basso, Giuseppe

AU - Pession, Andrea

AU - Biondi, Andrea

AU - Falini, Brunangelo

PY - 2005/8/15

Y1 - 2005/8/15

N2 - Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein involved in leukemia-associated chromosomal translocations, and it regulates the alternate reading frame (ARF)-p53 tumor-suppressor pathway. Recently, it has been demonstrated that mutations of the NPM1 gene alter the protein at its C-terminal, causing its cytoplasmic localization. Cytoplasmic NPM was detected in 35% of adult patients with primary non-French-American-British (FAB) classification M3 acute myeloid leukemia (AML), associated mainly with normal karyotype. We evaluated the prevalence of the NPM1 gene mutation in non-M3 childhood AML patients enrolled in the ongoing Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP-AML02) protocol in Italy. NPM1 mutations were found in 7 (6.5%) of 107 successfully analyzed patients. NPM1-mutated patients carried a normal karyotype (7/26, 27.1%) and were older in age. Thus, the NPM1 mutation is a frequent abnormality in AML patients without known genetic marker; the mutation may represent a new target to monitor minimal residual disease in AML and a potential candidate for alternative and targeted treatments.

AB - Nucleophosmin (NPM) is a nucleocytoplasmic shuttling protein involved in leukemia-associated chromosomal translocations, and it regulates the alternate reading frame (ARF)-p53 tumor-suppressor pathway. Recently, it has been demonstrated that mutations of the NPM1 gene alter the protein at its C-terminal, causing its cytoplasmic localization. Cytoplasmic NPM was detected in 35% of adult patients with primary non-French-American-British (FAB) classification M3 acute myeloid leukemia (AML), associated mainly with normal karyotype. We evaluated the prevalence of the NPM1 gene mutation in non-M3 childhood AML patients enrolled in the ongoing Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP-AML02) protocol in Italy. NPM1 mutations were found in 7 (6.5%) of 107 successfully analyzed patients. NPM1-mutated patients carried a normal karyotype (7/26, 27.1%) and were older in age. Thus, the NPM1 mutation is a frequent abnormality in AML patients without known genetic marker; the mutation may represent a new target to monitor minimal residual disease in AML and a potential candidate for alternative and targeted treatments.

UR - http://www.scopus.com/inward/record.url?scp=23744479178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744479178&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-03-0899

DO - 10.1182/blood-2005-03-0899

M3 - Article

VL - 106

SP - 1419

EP - 1422

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -